Gastrointestinal side effects like mild nausea or constipation peak during weeks 24 and often resolve by week 68 as your digestive system adapts
The following TaqMan primer sets were used: Ucp1 (Mm01244861_m1), Dio2 (Mm00515664_m1), Ppargc1 (Mm01208835_m1), Crh (Mm01293920_s1), Oxt (Mm01329577_g1), Trh (Mm01182425_g1), Pmch (Mm01242886_g1), Orx (Mm01964030_s1), Cartpt (Mm04210469_m1), Pomc (Mm00435874_m1), Npy (Mm00445771_m1) and Agrp (Mm00475829_g1)
Trava Health makes it easier than ever for individuals in Fishers to access effective obesity treatments and long-term weight management solutions
More frequent monitoring may be warranted during treatment initiation, dose escalation, or in patients with pre-existing chronic kidney disease or other risk factors
The SELECT trial showed it can reduce the risk by roughly 20%